David Linetsky - 17 Jul 2019 Form 3/A - Amendment Insider Report for Phreesia, Inc. (PHR)

Role
SVP, Life Sciences
Signature
/s/ Allison Hoffman by Power of Attorney for David Linetsky
Issuer symbol
PHR
Transactions as of
17 Jul 2019
Net transactions value
$0
Form type
3/A - Amendment
Filing time
10 Sep 2021, 17:16:13 UTC
Date Of Original Report
17 Jul 2019
Next filing
08 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PHR Stock Options (Right to buy) 17 Jul 2019 Common Stock 22,755 $4.71 Direct F1, F2
holding PHR Stock Options (Right to buy) 17 Jul 2019 Common Stock 34,132 $4.71 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F2 The original Form 3, filed on July 17, 2019, is being amended by this Form 3 amendment to correct the expiration date for this grant.
F3 25% of this option shall vest and become exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.